Transkaryotic Therapies' Unattributed VC - II Round

Transkaryotic Therapies raised a round of funding on October 01, 1995.

Transkaryotic Therapies (NASDAQ: TKTX) develops technologies for the production of human proteins and for gene therapy systems. Products developed with these technologies include ReplagalT, a drug app…

Articles about Transkaryotic Therapies' Unattributed VC - II Round: